.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Queensland Health
Fish and Richardson
Cantor Fitzgerald
Harvard Business School
Farmers Insurance
AstraZeneca
Citi
Fuji

Generated: December 13, 2017

DrugPatentWatch Database Preview

SARENIN Drug Profile

« Back to Dashboard

When do Sarenin patents expire, and what generic alternatives are available?

Sarenin is a drug marketed by Procter And Gamble and is included in one NDA.

The generic ingredient in SARENIN is saralasin acetate. Additional details are available on the saralasin acetate profile page.

Summary for SARENIN

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 6
Patent Applications: 4
Drug Prices:see details
DailyMed Link:SARENIN at DailyMed
Drug patent expirations by year for SARENIN

Medical Subject Heading (MeSH) Categories for SARENIN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Procter And GambleSARENINsaralasin acetateINJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SARENIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Procter And GambleSARENINsaralasin acetateINJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Procter And GambleSARENINsaralasin acetateINJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
UBS
Julphar
McKesson
Cantor Fitzgerald
McKinsey
Citi
Medtronic
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot